There are 3484 resources available
Introduction
Presenter: Bettina Ryll
Session: The importance to address the caregivers’ needs: The perspective of the caregivers
Resources:
Slides
Webcast
LBA18 - Pembrolizumab or placebo plus chemotherapy followed by pembrolizumab or placebo for early-stage TNBC: Updated EFS results from the phase III KEYNOTE-522 study
Presenter: Peter Schmid
Session: Proffered Paper session - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
LBA73 - Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study
Presenter: Salah-Eddin Al-Batran
Session: Proffered Paper session 1 - Gastrointestinal tumours, upper digestive
Resources:
Abstract
Slides
Webcast
LBA56 - Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)
Presenter: Jonathan Spicer
Session: Proffered Paper session - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Abstract
Slides
Webcast
My preferred choice is combined immunotherapy with PD1+CTLA-4, and these are the reasons why
Presenter: Ana Maria Arance Fernandez
Session: First-line therapy in advanced melanoma: What is my preferred choice?
Resources:
Slides
Webcast
Glioma beyond TMZ/RT
Presenter: Evanthia Galanis
Session: Neuro-Oncology 101: All you need to know to take care of brain tumour patients
Resources:
Slides
Webcast
Caregiver? Carer? Who are they?
Presenter: Stecy Yghemonos
Session: The importance to address the caregivers’ needs: The perspective of the caregivers
Resources:
Slides
Webcast
Optimizing oncologic care in older patients with advanced lung cancer
Presenter: Elisabeth Quoix
Session: In collaboration with SIOG: Fundamentals in geriatric oncology in clinical practice
Resources:
Slides
Webcast
A guide through the new ESMO-MCBS v2.0
Presenter: Nathan Cherny
Session: ESMO-MCBS: 2023 revolution
Resources:
Slides
Webcast
How tumour-draining lymph nodes inform the content of the TME and vice versa
Presenter: Tanja de Gruijl
Session: Therapeutic view on tumour immune microenvironment: It's TIME
Resources:
Slides
Webcast